- Investing Ideas
- /
- Chinese Healthcare Solid Balance Sheet and Fundamentals
Chinese Healthcare Solid Balance Sheet and Fundamentals
Results
4
High return on equity, past performance and sound balance sheet.
4 companies
APT Medical
Market Cap: CN¥41.5b
Engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China.
688617
CN¥294.11
7D
0.7%
1Y
31.7%
Jafron BiomedicalLtd
Market Cap: CN¥17.5b
Engages in the research, development, production, and sales of blood purification products for hemadsorption field in worldwide.
300529
CN¥22.59
7D
0.8%
1Y
-15.5%
Shenzhen New Industries Biomedical Engineering
Market Cap: CN¥42.6b
Engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally.
300832
CN¥54.26
7D
0.8%
1Y
-14.4%
Tibet Rhodiola Pharmaceutical Holding
Market Cap: CN¥12.9b
Tibet Rhodiola Pharmaceutical Holding Co.
600211
CN¥39.94
7D
5.2%
1Y
24.7%